Polyacetal polymers, conjugates, particles and uses thereof
US-2018360978-A1 · Dec 20, 2018 · US
Pharmaceutical prodrugs and methods of their preparation and use
US11071789B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11071789-B2 |
| Application number | US-201716316451-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 13, 2017 |
| Priority date | Jul 13, 2016 |
| Publication date | Jul 27, 2021 |
| Grant date | Jul 27, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The disclosure provides compounds of Formula (I), wherein X, Y, and Z are defined herein. The disclosure also provides particles comprising one or more compounds described herein, compositions comprising one or more compounds or particles described herein and a pharmaceutically acceptable carrier, and methods of treating a subject in need thereof comprising administering one or more compounds, particles, or compositions described herein to the subject. X—Y—Z (I).
First claim
Opening claim text (preview).
What is claimed is: 1. Particles comprising one or more compounds that are: 2. The particles of claim 1 , which are nano-particles or microparticles. 3. The particles of claim 2 , further comprising a diblock or triblock copolymer. 4. A composition comprising the particles of claim 1 and a pharmaceutically acceptable carrier. 5. The composition of claim 4 in the form of a suspension, emulsion, dispersion, or depot. 6. Particles comprising one or more compounds that are: 7. Particles comprising one or more compounds that are:
Assignees
Inventors
Classifications
Triazine radicals · CPC title
Polyesters, e.g. poly(lactide-co-glycolide) · CPC title
Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine · CPC title
Acyclic or carbocyclic radicals, substituted by hetero rings · CPC title
Carboxylic acids, e.g. a fatty acid or an amino acid · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11071789B2 cover?
- The disclosure provides compounds of Formula (I), wherein X, Y, and Z are defined herein. The disclosure also provides particles comprising one or more compounds described herein, compositions comprising one or more compounds or particles described herein and a pharmaceutically acceptable carrier, and methods of treating a subject in need thereof comprising administering one or more compounds, …
- Who is the assignee on this patent?
- Cephalon Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K47/6937. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).